Noile-Immune Biotech Inc. (TSE: 4893)
Health Care · Biotechnology · JP
¥142.00
+2.16% today · -19.8% 1Y
Noile-Immune Biotech Inc. (TSE: 4893) operates in the Biotechnology industry within the Health Care sector. The company is valued at $38.73M and employs 23 people.
Over the last twelve months the share price has lost 19.8%, trading between 114.00 and 217.00.
Tweenvest scores Noile-Immune Biotech Inc. across four factors: quality 31/100, value 43/100, growth 0/100. Its strongest factor is value.
4893 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $38.73M
- Revenue (TTM)
- $18.87K
- P/E
- —
- EPS
- -16.30
- Dividend yield
- —
- Beta (5Y)
- 0.10
- 52-week high
- ¥217.00
- 52-week low
- ¥114.00
- Avg volume (3M)
- —
- Shares outstanding
- 43.40M
- Employees
- 23
- Next earnings
- —
About Noile-Immune Biotech Inc.
Established in 2015 and based in Minato, Japan, this company is dedicated to exploring and advancing CAR-T cell technology for use in cancer immunotherapy treatments.
- ISIN
- JP3759560000
- Founded
- 2015
- Listed since
- Jun 28, 2023
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $467.44B | $264.52 | -0.17% |
| Amgen Inc.NasdaqGS: AMGN | $239.95B | $443.84 | +1.03% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.95B | $146.74 | +0.42% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.79B | $547.59 | -0.08% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $82.73B | $828.50 | -0.66% |
| argenx SEENXTBR: ARGX | $63.06B | €874.20 | +1.16% |
| CSL LimitedASX: CSL | $57.94B | AU$169.11 | +0.48% |
| Moderna, Inc.NasdaqGS: MRNA | $55.45B | $141.77 | +2.07% |
Figures last refreshed Aug 18, 2026.